BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
15 results:

  • 1. Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY.
    Pearce FA; Lim SH; Bythell M; Lanyon P; Hogg R; Taylor A; Powter G; Cooke GS; Ward H; Chilcot J; Thomas H; Mumford L; McAdoo SP; Pettigrew GJ; Lightstone L; Willicombe M
    Lancet Rheumatol; 2023 Aug; 5(8):e461-e473. PubMed ID: 38251578
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Predictive value of CXCL10 for the occurrence of immune-related adverse events in patient with renal cell carcinoma.
    Miura Y; Motoshima T; Anami T; Yano H; Mito R; Pan C; Urakami S; Kinowaki K; Tsukamoto H; Kurahashi R; Murakami Y; Yatsuda J; Fujiwara Y; Kamba T; Komohara Y
    Microbiol Immunol; 2023 Jul; 67(7):345-354. PubMed ID: 36975091
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Real-World Multi-Institutional Analysis.
    Ghatalia P; Handorf EA; Geynisman DM; Deng M; Zibelman MR; Abbosh P; Anari F; Greenberg RE; Viterbo R; Chen D; Smaldone MC; Kutikov A; Uzzo RG
    J Urol; 2022 Jul; 208(1):71-79. PubMed ID: 35212574
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy.
    Mizuno R; Takamatsu K; Yasumizu Y; Tanaka N; Takeda T; Morita S; Matsumoto K; Kosaka T; Asanuma H; Mikami S; Oya M
    Urol Int; 2022; 106(11):1145-1149. PubMed ID: 35139522
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MR-Guided Microwave Ablation in T1 Renal Cell Carcinoma: Initial Results in Clinical Routine.
    Li Z; Jiao DC; Wang C; Zhang W; Li J; Han X
    Biomed Res Int; 2021; 2021():5537192. PubMed ID: 34055980
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development and validation of a CT-based nomogram for preoperative prediction of clear cell renal cell carcinoma grades.
    Zheng Z; Chen Z; Xie Y; Zhong Q; Xie W
    Eur Radiol; 2021 Aug; 31(8):6078-6086. PubMed ID: 33515086
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort Study.
    Raymakers-Janssen PAMA; Lilien MR; Tibboel D; Kneyber MCJ; Dijkstra S; van Woensel JBM; Lemson J; Cransberg K; van den Heuvel-Eibrink MM; Wösten-van Asperen RM;
    Crit Care Med; 2019 Nov; 47(11):e893-e901. PubMed ID: 31464768
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Robot-assisted partial nephrectomy for large renal masses: a multi-institutional series.
    Delto JC; Paulucci D; Helbig MW; Badani KK; Eun D; Porter J; Abaza R; Hemal AK; Bhandari A
    BJU Int; 2018 Jun; 121(6):908-915. PubMed ID: 29357404
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Potential health gains for patients with metastatic renal cell carcinoma in daily clinical practice: A real-world cost-effectiveness analysis of sequential first- and second-line treatments.
    De Groot S; Blommestein HM; Redekop WK; Sleijfer S; Kiemeney LALM; Oosterwijk E; Uyl-de Groot CA
    PLoS One; 2017; 12(5):e0177364. PubMed ID: 28531203
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Nephron Sparing Surgery Associated With Better Survival Than Radical Nephrectomy in Patients Treated for Unforeseen Benign Renal tumors.
    Ljungberg B; Hedin O; Lundstam S; Warnolf Å; Mandahl Forsberg A; Hjelle KM; Stief CG; Borlinghaus C; Beisland C; Staehler M
    Urology; 2016 Jul; 93():117-23. PubMed ID: 27017902
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.
    Vigneau C; Lorcy N; Dolley-Hitze T; Jouan F; Arlot-Bonnemains Y; Laguerre B; Verhoest G; Goujon JM; Belaud-Rotureau MA; Rioux-Leclercq N
    Nephrol Dial Transplant; 2014 Feb; 29(2):325-32. PubMed ID: 24302609
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Psoriasis and risk of incident cancer: an inception cohort study with a nested case-control analysis.
    Brauchli YB; Jick SS; Miret M; Meier CR
    J Invest Dermatol; 2009 Nov; 129(11):2604-12. PubMed ID: 19440219
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Early and late mortality after diagnosis of wilms tumor.
    Cotton CA; Peterson S; Norkool PA; Takashima J; Grigoriev Y; Green DM; Breslow NE
    J Clin Oncol; 2009 Mar; 27(8):1304-9. PubMed ID: 19139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Epidemiology and treatment of renal pelvic and ureteral tumors.
    Petković SD
    J Urol; 1975 Dec; 114(6):858-65. PubMed ID: 1195463
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.